Denosumab for the Treatment of Osteoporosis in Children: A Pilot Study

NCT02632916 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Osteoporosis

Interventions

DRUG: Zoledronic Acid
DRUG: Denosumab

Sponsor

Children's Hospital of Eastern Ontario